Top Markets
Coin of the day
Avidity Biosciences Inc Avidity Biosciences Inc

Avidity Biosciences Inc

RNAM
Classement en actions #2179
Avidity Biosciences, Inc. is at the forefront of developing a novel class of... Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.
Prix de l'action
$71.34
Dernière synchronisation: 2026-03-03
Capitalisation boursière
$9.84B
Changement (1 jour)
0.00%
Changement (1 an)
-
Pays
US
Échange Avidity Biosciences Inc (RNAM)

Catégorie

Ratio P/B pour Avidity Biosciences Inc (RNAM)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Avidity Biosciences Inc, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Avidity Biosciences Inc de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH